Literature DB >> 3158660

Purification and characterization of phospholamban from canine cardiac sarcoplasmic reticulum.

L R Jones, H K Simmerman, W W Wilson, F R Gurd, A D Wegener.   

Abstract

Phospholamban, the putative protein regulator of the Ca2+ pump of cardiac sarcoplasmic reticulum, was purified to apparent homogeneity from canine cardiac sarcoplasmic reticulum vesicles by selective extraction with sodium cholate, followed by adsorption to calcium oxalate, solubilization in Zwittergent 3-14, and specific elution from p-hydroxymercuribenzoate-agarose. Phospholamban, isolated in the dephosphorylated state, was purified 80-fold in 15% yield (approximately 2 mg of phospholamban/g of sarcoplasmic reticulum protein). Nondissociated phospholamban exhibited an apparent Mr = 25,000 in sodium dodecyl sulfate-polyacrylamide gels. Partially dissociated phospholamban, induced by boiling in sodium dodecyl sulfate, exhibited five distinct mobility forms in sodium dodecyl sulfate-polyacrylamide gels, of apparent molecular weights between 5,000-6,000 and 25,000. Phospholamban was phosphorylated to a level of 190 nmol of Pi/mg of protein by cAMP-dependent protein kinase, consistent by minimum stoichiometry with a subunit molecular weight of approximately 5,000. Phospholamban prepared by the present method was different in several respects from the proteins that have been isolated in other laboratories. Pure phospholamban was cysteine rich, containing 6 residues/100 amino acid residues. Dephosphorylated phospholamban was strongly basic with a pI = 10; phosphorylation decreased the pI to approximately 6.7. Pure phospholamban (and phospholamban present in sarcoplasmic reticulum vesicles) was not readily extracted into acidified chloroform/methanol, suggesting that the protein does not behave as an acidic proteolipid. The purified protein was highly antigenic. Phospholamban was localized by immunochemical methods to cardiac membranes enriched in sarcoplasmic reticulum, but was absent from sarcoplasmic reticulum membranes prepared from fast skeletal muscle. The method described for isolation of cardiac phospholamban is highly reproducible and relatively simple, and should be useful for further detailed studies designed to probe the molecular structure of the protein.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3158660

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Computational design of a water-soluble analog of phospholamban.

Authors:  Avram M Slovic; Christopher M Summa; James D Lear; William F DeGrado
Journal:  Protein Sci       Date:  2003-02       Impact factor: 6.725

2.  The structural basis for phospholamban inhibition of the calcium pump in sarcoplasmic reticulum.

Authors:  Brandy L Akin; Thomas D Hurley; Zhenhui Chen; Larry R Jones
Journal:  J Biol Chem       Date:  2013-08-31       Impact factor: 5.157

3.  Age-related regulation of excitation-contraction coupling in rat heart.

Authors:  Hilmi B Kandilci; Erkan Tuncay; Esma N Zeydanli; Nazli N Sozmen; Belma Turan
Journal:  J Physiol Biochem       Date:  2011-02-02       Impact factor: 4.158

4.  The role of phospholamban in the regulation of calcium transport by cardiac sarcoplasmic reticulum.

Authors:  B A Davis; I Edes; R C Gupta; E F Young; H W Kim; N A Steenaart; G Szymanska; E G Kranias
Journal:  Mol Cell Biochem       Date:  1990-12-20       Impact factor: 3.396

5.  On the mechanism of the reduction by thyroid hormone of beta-adrenergic relaxation rate stimulation in rat heart.

Authors:  R E Beekman; C van Hardeveld; W S Simonides
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

6.  Phospholamban is a good substrate for cyclic GMP-dependent protein kinase in vitro, but not in intact cardiac or smooth muscle.

Authors:  J P Huggins; E A Cook; J R Piggott; T J Mattinsley; P J England
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

7.  Complete complementary DNA-derived amino acid sequence of canine cardiac phospholamban.

Authors:  J Fujii; A Ueno; K Kitano; S Tanaka; M Kadoma; M Tada
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

8.  Molecular dynamics in mouse atrial tumor sarcoplasmic reticulum.

Authors:  J C Voss; J E Mahaney; L R Jones; D D Thomas
Journal:  Biophys J       Date:  1995-05       Impact factor: 4.033

9.  Inhibition of Ca2+ transport associated with cAMP-dependent protein phosphorylation in rat cardiac sarcoplasmic reticulum by triorganotins.

Authors:  P R Kodavanti; J A Cameron; P R Yallapragada; P J Vig; D Desaiah
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

10.  Characterization of the molecular form of cardiac phospholamban.

Authors:  J M Harrer; E G Kranias
Journal:  Mol Cell Biochem       Date:  1994-11-23       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.